Changes in microRNA expression during disease progression in patients with chronic viral hepatitis

Alessandro Sinigaglia, Enrico Lavezzo, Marta Trevisan, Tiziana Sanavia, Barbara Di Camillo, Elektra Peta, Melania Scarpa, Ignazio Castagliuolo, Maria Guido, Samantha Sarcognato, Rocco Cappellesso, Ambrogio Fassina, Romilda Cardin, Fabio Farinati, Giorgio Palù, Luisa Barzon

Research output: Contribution to journalArticlepeer-review


MicroRNAs (miRNAs) have been involved in hepatocarcinogenesis, but little is known on their role in the progression of chronic viral hepatitis. Aim of this study was to identify miRNA signatures associated with stages of disease progression in patients with chronic viral hepatitis. Methods: MiRNA expression profile was investigated in liver biopsies from patients with chronic viral hepatitis and correlated with clinical, virological and histopathological features. Relevant miRNAs were further investigated. Results: Most of the significant changes in miRNA expression were associated with liver fibrosis stages and included the significant up-regulation of a group of miRNAs that were demonstrated to target the master regulators of epithelial-mesenchymal transition ZEB1 and ZEB2 and involved in the preservation of epithelial cell differentiation, but also in cell proliferation and fibrogenesis. In agreement with miRNA data, immunostaining of liver biopsies showed that expression of the epithelial marker E-cadherin was maintained in severe fibrosis/cirrhosis while expression of ZEBs and other markers of epithelial-mesenchymal transition were low or absent. Severe liver fibrosis was also significantly associated with the down-regulation of miRNAs with antiproliferative and tumour suppressor activity. Similar changes in miRNA and target gene expression were demonstrated along with disease progression in a mouse model of carbon tetrachloride (CCl4)-induced liver fibrosis, suggesting that they might represent a general response to liver injury. Conclusion: Chronic viral hepatitis progression is associated with the activation of miRNA pathways that promote cell proliferation and fibrogenesis, but preserve the differentiated hepatocyte phenotype.

Original languageEnglish
Pages (from-to)1324-1333
Number of pages10
JournalLiver International
Issue number4
Publication statusPublished - Apr 1 2015


  • Chronic viral hepatitis
  • Epithelial-mesenchymal transition
  • Liver fibrosis
  • Liver injury
  • MicroRNA

ASJC Scopus subject areas

  • Hepatology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Changes in microRNA expression during disease progression in patients with chronic viral hepatitis'. Together they form a unique fingerprint.

Cite this